ITLN1 and type 2 diabetes mellitus: This effect was also observed in another study enrolling non-T2DM patients, in which increased circulating omentin levels were further associated with increased insulin sensitivity and with reduced BMI, systolic and diastolic blood pressure, and IL-6 and CRP-1 levels [302].